Syngenta has announced it will cease production of the pesticide paraquat, commonly linked to Parkinson’s disease, by the end of June, amid ongoing lawsuits alleging health risks from its use.
Syngenta, a significant player in the agricultural chemicals market, has declared it will halt the manufacturing of paraquat, a weed killer associated with an increased risk of Parkinson's disease, by the end of June. This decision arrives in the shadow of numerous lawsuits filed in the United States, whereby plaintiffs contend that their Parkinson’s disease was a result of exposure to paraquat. While the company has not commented on these legal challenges, the announcement indicated a strategic business decision rather than a concession regarding the product’s safety.
The company cited 'significant competition' from generic manufacturers and a minimal contribution of less than one percent to its overall sales as core reasons for exiting the paraquat market. Mike Hollands, president of Syngenta UK, emphasized that this shift allows the company to realign its resources towards more valuable sectors for both the business and its customers.
Despite moving away from paraquat production, Syngenta has reiterated their stance that when applied correctly, paraquat remains safe. This declaration signifies a broader concern in the agricultural sector regarding chemical safety, regulatory scrutiny, and public health implications, as the discussions around pesticides and their health consequences intensify in society.
